These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 9665228

  • 1. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
    Herrington DM, Fong J, Sempos CT, Black DM, Schrott HG, Rautaharju P, Bachorik PS, Blumenthal R, Khan S, Wenger NK.
    Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228
    [Abstract] [Full Text] [Related]

  • 2. Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.
    Grady D, Applegate W, Bush T, Furberg C, Riggs B, Hulley SB.
    Control Clin Trials; 1998 Aug; 19(4):314-35. PubMed ID: 9683309
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N, HERS Research Group.
    JAMA; 2002 Jul 03; 288(1):49-57. PubMed ID: 12090862
    [Abstract] [Full Text] [Related]

  • 4. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.
    JAMA; 2000 Apr 12; 283(14):1845-52. PubMed ID: 10770146
    [Abstract] [Full Text] [Related]

  • 5. The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).
    Simon JA, Lin F, Vittinghoff E, Bittner V, Heart and Estrogen-Progestin Replacement Study (HERS) Research Group.
    Ann Epidemiol; 2006 Feb 12; 16(2):138-45. PubMed ID: 16039873
    [Abstract] [Full Text] [Related]

  • 6. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S.
    JAMA; 2006 Feb 12; 277(16):1281-6. PubMed ID: 9109465
    [Abstract] [Full Text] [Related]

  • 7. Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?
    Shlipak MG, Stehman-Breen C, Vittinghoff E, Lin F, Varosy PD, Wenger NK, Furberg CD, Heart and Estrogen/Progestin Replacement Study (HERS) Investigators.
    Am J Kidney Dis; 2004 Jan 12; 43(1):37-44. PubMed ID: 14712425
    [Abstract] [Full Text] [Related]

  • 8. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I, Parra D.
    Am J Health Syst Pharm; 2000 Nov 01; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [Abstract] [Full Text] [Related]

  • 9. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Pickar JH.
    Ann Intern Med; 2001 Oct 02; 135(7):493-501. PubMed ID: 11578152
    [Abstract] [Full Text] [Related]

  • 10. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).
    Shlipak MG, Chaput LA, Vittinghoff E, Lin F, Bittner V, Knopp RH, Hulley SB, Heart and Estrogen/progestin Replacement Study Investigators.
    Am Heart J; 2003 Nov 02; 146(5):870-5. PubMed ID: 14597937
    [Abstract] [Full Text] [Related]

  • 11. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women.
    Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P.
    Atherosclerosis; 1995 Nov 02; 118(1):123-33. PubMed ID: 8579622
    [Abstract] [Full Text] [Related]

  • 12. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.
    Rosano GM, Fini M.
    Cardiol Rev; 2002 Nov 02; 10(1):51-60. PubMed ID: 11790270
    [Abstract] [Full Text] [Related]

  • 13. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS).
    Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett-Connor E, Hulley SB.
    Circulation; 2001 Feb 06; 103(5):638-42. PubMed ID: 11156873
    [Abstract] [Full Text] [Related]

  • 14. Hormones and heart disease in women: Heart and Estrogen/Progestin Replacement Study in perspective.
    Barrett-Connor E, Stuenkel C.
    J Clin Endocrinol Metab; 1999 Jun 06; 84(6):1848-53. PubMed ID: 10372673
    [Abstract] [Full Text] [Related]

  • 15. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 Jun 06; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 16. The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study.
    Herrington DM.
    Ann Intern Med; 1999 Sep 21; 131(6):463-6. PubMed ID: 10498564
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C, Hinke V, Lange S, Fricke R, Botko R, Pfeilschifter J.
    Exp Clin Endocrinol Diabetes; 2005 Oct 21; 113(9):529-33. PubMed ID: 16235155
    [Abstract] [Full Text] [Related]

  • 19. Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.
    Nair GV, Chaput LA, Vittinghoff E, Herrington DM, Heart and Estrogen/Progestin Replacement Study Investigators.
    Chest; 2005 May 21; 127(5):1498-506. PubMed ID: 15888820
    [Abstract] [Full Text] [Related]

  • 20. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B, Mehta JL.
    Curr Opin Cardiol; 2007 Sep 21; 22(5):434-42. PubMed ID: 17762545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.